Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Q2 FY2021
As of Jul 9, 2021
ASSETS
Current assets:
Cash and cash equivalents
Restricted cash
Prepaid assets
Other current assets
Total current assets
Property and equipment, net
Intangible assets, net
Long-term investments
Convertible note
Equity method investments
Operating lease asset
Right-of-use asset under operating leases
Other long-term assets
Total assets
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Advance of equity contribution
Accounts payable
Accrued liabilities and other
Accounts payable and accrued liabilities - related party
Deferred income
Share-based compensation liability
Other current liabilities
Total current liabilities
Warrant liability
Operating lease liability
Long-term share-based compensation liability
Other long-term liabilities
Total liabilities
Shareholders’ equity:
Ordinary share capital, no par value, 245,000 ordinary shares authorized, and 139,854 and 139,705 ordinary shares issued and outstanding, respectively, as of both September 30, 2023 and December 31, 2022
Additional paid-in capital
Treasury stock
Accumulated other comprehensive (loss) income
Accumulated deficit
Total ordinary shareholders' equity
Non-controlling interests
Total equity
Total liabilities and equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support